Contact Us
Contact Us
Contact Us

Proactive Investor interviews John Cullity

Race Oncology Non-Executive Director Dr. John Cullity speaks with Proactive Investors about the company’s cancer chemotherapy drug, Bisantrene.

Watch the video here.

  • Share this post

Previous Article New director upbeat about Race Oncology's growth prospects

Comments

Leave a Comment

© 2018 Race Oncology. Website By Glide Agency